Cassiopea Partners acted as sole financial advisor to Mandarin Capital Partners II ("MCP II") and other shareholders in the sale of 100% of Mipharm (or the “Company”) to Alto Partners. Mipharm S.p.A. (“Mipharm” or the “Company”) is a Milan-based company recognized among the Italian leaders in the production of...
Cassiopea Partners advised Mandarin Capital Partners on the sale of Mipharm to Alto Partners
